274 related articles for article (PubMed ID: 26376963)
1. Immunotherapy of Melanoma.
Snyder A; Zamarin D; Wolchok JD
Prog Tumor Res; 2015; 42():22-9. PubMed ID: 26376963
[TBL] [Abstract][Full Text] [Related]
2. Next generation of immunotherapy for melanoma.
Kirkwood JM; Tarhini AA; Panelli MC; Moschos SJ; Zarour HM; Butterfield LH; Gogas HJ
J Clin Oncol; 2008 Jul; 26(20):3445-55. PubMed ID: 18612161
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of melanoma.
Kee D; McArthur G
Eur J Surg Oncol; 2017 Mar; 43(3):594-603. PubMed ID: 27514721
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy as an adjuvant therapy in the management of advanced, surgically resected, melanoma.
Kalani AD; Jack A; Montenegro G; Degliuomini J; Wallack MK
G Ital Dermatol Venereol; 2008 Feb; 143(1):59-70. PubMed ID: 18833052
[TBL] [Abstract][Full Text] [Related]
5. Nivolumab and pembrolizumab as immune-modulating monoclonal antibodies targeting the PD-1 receptor to treat melanoma.
Faghfuri E; Faramarzi MA; Nikfar S; Abdollahi M
Expert Rev Anticancer Ther; 2015; 15(9):981-93. PubMed ID: 26313415
[TBL] [Abstract][Full Text] [Related]
6. Melanoma and immunotherapy.
Eggermont AM; Schadendorf D
Hematol Oncol Clin North Am; 2009 Jun; 23(3):547-64, ix-x. PubMed ID: 19464602
[TBL] [Abstract][Full Text] [Related]
7. [Immunotherapies and melanoma].
Routier É; Robert C; Mateus C
Bull Cancer; 2014 Dec; 101 Suppl 2():S13-24. PubMed ID: 25776763
[TBL] [Abstract][Full Text] [Related]
8. New developments in the treatment of metastatic melanoma: immune checkpoint inhibitors and targeted therapies.
Azijli K; Stelloo E; Peters GJ; VAN DEN Eertwegh AJ
Anticancer Res; 2014 Apr; 34(4):1493-505. PubMed ID: 24692676
[TBL] [Abstract][Full Text] [Related]
9. Immune checkpoint inhibitors in melanoma provide the cornerstones for curative therapies.
Eggermont AM; Maio M; Robert C
Semin Oncol; 2015 Jun; 42(3):429-35. PubMed ID: 25965361
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapies in Early and Advanced Renal Cell Cancer.
Kasenda B; Larkin J; Gore M
Prog Tumor Res; 2015; 42():1-10. PubMed ID: 26376844
[TBL] [Abstract][Full Text] [Related]
11. Cancer immunotherapy: the beginning of the end of cancer?
Farkona S; Diamandis EP; Blasutig IM
BMC Med; 2016 May; 14():73. PubMed ID: 27151159
[TBL] [Abstract][Full Text] [Related]
12. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens.
Gubin MM; Zhang X; Schuster H; Caron E; Ward JP; Noguchi T; Ivanova Y; Hundal J; Arthur CD; Krebber WJ; Mulder GE; Toebes M; Vesely MD; Lam SS; Korman AJ; Allison JP; Freeman GJ; Sharpe AH; Pearce EL; Schumacher TN; Aebersold R; Rammensee HG; Melief CJ; Mardis ER; Gillanders WE; Artyomov MN; Schreiber RD
Nature; 2014 Nov; 515(7528):577-81. PubMed ID: 25428507
[TBL] [Abstract][Full Text] [Related]
13. Current perspectives on immunotherapy.
Weber JS
Semin Oncol; 2014 Oct; 41 Suppl 5():S14-29. PubMed ID: 25438996
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant therapy for malignant melanoma.
Stoutenburg JP; Schrope B; Kaufman HL
Expert Rev Anticancer Ther; 2004 Oct; 4(5):823-35. PubMed ID: 15485316
[TBL] [Abstract][Full Text] [Related]
15. Cancer immunology - development of novel anti-cancer therapies.
Rothschild SI; Thommen DS; Moersig W; Müller P; Zippelius A
Swiss Med Wkly; 2015; 145():w14066. PubMed ID: 25668078
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of melanoma: present options and future promises.
Rotte A; Bhandaru M; Zhou Y; McElwee KJ
Cancer Metastasis Rev; 2015 Mar; 34(1):115-28. PubMed ID: 25589384
[TBL] [Abstract][Full Text] [Related]
17. Update on vaccines for high-risk melanoma.
Weiss SA; Chandra S; Pavlick AC
Curr Treat Options Oncol; 2014 Jun; 15(2):269-80. PubMed ID: 24788575
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy of melanoma: efficacy and mode of action.
Wieder T; Brenner E; Braumüller H; Röcken M
J Dtsch Dermatol Ges; 2016 Jan; 14(1):28-37. PubMed ID: 26713633
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of Breast Cancer.
Criscitiello C; Curigliano G
Prog Tumor Res; 2015; 42():30-43. PubMed ID: 26377084
[TBL] [Abstract][Full Text] [Related]
20. Combination Immunotherapy: Taking Cancer Vaccines to the Next Level.
Grenier JM; Yeung ST; Khanna KM
Front Immunol; 2018; 9():610. PubMed ID: 29623082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
